JCDecaux : Q1 2026 – Business review

Please find attached our quarterly report for the first quarter of 2026.

Kind regards.

Attachment

• 05-05-25 # Q1 2026 Business Review

You May Also Be Interested In

• Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate
• Last Chance to Join the Apeing Whitelist Before This Upcoming Crypto Coin Rivals Monero and Ethereum
• Bitcoin Targets $77K After a Short Squeeze as XRP Jumps 20% and Apeing Enters the Best Upcoming Crypto Presale Race